Interventional VSD-Closure with the Nit-Occlud® Lê VSD-Coil in 110 Patients: Early and Midterm Results of the EUREVECO-Registry
Heart Septal Defects, Ventricular
Male
Cardiac Catheterization
Adolescent
Septal Occluder Device
Operative Time
610 Medicine & health
Perimembranous VSD
Nit-Occlud (R)
Hemolysis
2705 Cardiology and Cardiovascular Medicine
Congenital heart defects; EUREVECO; Interventional VSD closure; Muscular VSD; Nit-Occlud® Lê-VSD-Coil; Perimembranous VSD; Pediatrics, Perinatology and Child Health; Cardiology and Cardiovascular Medicine
03 medical and health sciences
Muscular VSD
0302 clinical medicine
Humans
2735 Pediatrics, Perinatology and Child Health
Registries
Child
Interventional VSD closure
Retrospective Studies
Infant
Le-VSD-Coil
3. Good health
Europe
EUREVECO
Treatment Outcome
Congenital heart defects
10036 Medical Clinic
Child, Preschool
Fluoroscopy
Female
DOI:
10.1007/s00246-016-1502-8
Publication Date:
2016-11-15T07:44:05Z
AUTHORS (20)
ABSTRACT
In August 2010, the Nit-Occlud® Lê (EUREVECO) became available for transcatheter coil occlusion of ventricular septal defects (VSDs). Retrospective European Registry for VSD Closure using the Nit-Occlud® Lê-VSD-Coil; analysis of the feasibility, results, safety and follow-up of VSD-closure over a 3-year period in 18 European centers. In 102 of 111 patients (female 66), successful VSD closure was performed (mean age 8.2 years, mean weight 28.82 kg), 81 perimembranous VSDs (48 with aneurysm), 30 muscular VSDs, mean procedure time was 121.1 min, and mean fluoroscopy time was 26.3 min. Short- and midterm term follow-up was possible in 100/102 patients, there was 1 embolization and 1 explantation after 24 months. Immediate complete closure occurred in 49 of 101 patients (48.5%), trivial residual shunt was present in 51 (50.0%), closure rate was 95% after 6 months and 97% after 1 year. Out of the 102 patients, there were 2 severe complications (1.8%) (1 severe hemolysis, 1 embolization) and 8 moderate/transient (=7.2%) including 1 transient AV block. During a mean follow-up period of 31.3 months (range 24-48) and a total follow-up time of 224.75 patient years, no further problems occurred. VSD closure with the Nit-Occlud® Lê VSD coil is feasible and safe with a minimal risk of severe side effects. The long-term effects and safety require further clinical follow-up studies.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (31)
CITATIONS (44)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....